These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10379699)

  • 21. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
    Kaul S; Diamond GA
    Prog Cardiovasc Dis; 2007; 49(4):284-99. PubMed ID: 17185116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
    Hida E; Tango T
    J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women.
    Beksinska M; Smit J; Mabude Z; Vijayakumar G; Joanis C
    Contraception; 2006 Apr; 73(4):386-93. PubMed ID: 16531173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpreting sexually transmissible infection prevention trials by adjusting for the magnitude of exposure.
    Wilson DP
    Clin Trials; 2010 Feb; 7(1):36-43. PubMed ID: 20007407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical analysis of clinical trials.
    Wassertheil-Smoller S; Kim MY
    Semin Nucl Med; 2010 Sep; 40(5):357-63. PubMed ID: 20674595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using the instrumental variables estimator to analyze noninferiority trials with noncompliance.
    Kim MY
    J Biopharm Stat; 2010 Jul; 20(4):745-58. PubMed ID: 20496203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing noninferiority in a three-arm trial using the Bayesian approach.
    Ghosh P; Nathoo F; Gönen M; Tiwari RC
    Stat Med; 2011 Jul; 30(15):1795-808. PubMed ID: 21520456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A note on non-parametric ANCOVA for covariate adjustment in randomized clinical trials.
    Lesaffre E; Senn S
    Stat Med; 2003 Dec; 22(23):3583-96. PubMed ID: 14652862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small-sample performance of the robust score test and its modifications in generalized estimating equations.
    Guo X; Pan W; Connett JE; Hannan PJ; French SA
    Stat Med; 2005 Nov; 24(22):3479-95. PubMed ID: 15977302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized crossover trial of the impact of additional spermicide on condom failure rates.
    Gabbay MB; Thomas J; Gibbs A; Hold P
    Sex Transm Dis; 2008 Oct; 35(10):862-8. PubMed ID: 18685543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large sample tests for binary outcomes in fixed-dose combination drug studies.
    Wang SJ; Hung HM
    Biometrics; 1997 Jun; 53(2):498-503. PubMed ID: 9192448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of intention to treat in analysis of noninferiority studies.
    Wiens BL; Zhao W
    Clin Trials; 2007; 4(3):286-91. PubMed ID: 17715258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and analysis of crossover trials for absorbing binary endpoints.
    Nason M; Follmann D
    Biometrics; 2010 Sep; 66(3):958-65. PubMed ID: 19930189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistical assessment of QT/QTc prolongation based on maximum of correlated normal random variables.
    Cheng B; Chow SC; Burt D; Cosmatos D
    J Biopharm Stat; 2008; 18(3):494-501. PubMed ID: 18470758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditional and exact tests in crossover trials.
    Patefield M
    J Biopharm Stat; 2000 Feb; 10(1):109-29. PubMed ID: 10709805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring rare serious adverse events from a new treatment and testing for a difference from historical controls.
    Fay MP; Huang CY; Twum-Danso NA
    Clin Trials; 2007; 4(6):598-610. PubMed ID: 18042569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and analysis of trials with rare outcomes: examples from trials in herpes transmission and influenza prophylaxis.
    Keene O
    Contemp Clin Trials; 2005 Jun; 26(3):311-22. PubMed ID: 15911465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized clinical trial design for assessing noninferiority when superiority is expected.
    Freidlin B; Korn EL; George SL; Gray R
    J Clin Oncol; 2007 Nov; 25(31):5019-23. PubMed ID: 17971602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Likelihood ratio and a Bayesian approach were superior to standard noninferiority analysis when the noninferiority margin varied with the control event rate.
    Kim MY; Xue X
    J Clin Epidemiol; 2004 Dec; 57(12):1253-61. PubMed ID: 15617951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.